T. Pickles

发表

125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy.

Tom Pickles, Mira Keyes, W James Morris, 2004, International journal of radiation oncology, biology, physics.

Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer.

W. J. Morris, I. Spadinger, M. Keyes, 2009, International journal of radiation oncology, biology, physics.

The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy.

W. J. Morris, I. Spadinger, M. Keyes, 2011, Brachytherapy.

Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: a long-term study in 1006 patients.

Howard Pai, Ingrid Spadinger, Ross Halperin, 2012, Brachytherapy.

Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer.

W. J. Morris, I. Spadinger, M. Keyes, 2009, Urology.

Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.

M. Roobol, A. Briganti, T. Pickles, 2015, European urology.

Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.

J. Connors, K. Savage, S. Tyldesley, 2015, International journal of radiation oncology, biology, physics.

Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.

W. J. Morris, M. Keyes, J. Crook, 2015, Brachytherapy.

Pride or prejudice: does Phoenix flatter radiation therapy?

W. J. Morris, I. Spadinger, M. Keyes, 2013, Brachytherapy.

Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy patients.

Ingrid Spadinger, Michael McKenzie, Tom Pickles, 2014, Brachytherapy.

Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer

Howard Pai, Ingrid Spadinger, Scott Tyldesley, 2013, Cancer.

A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer.

T. Pickles, Y. D'yachkova, G. Campbell, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer.

S. Tyldesley, T. Pickles, K. Chi, 2019, Practical radiation oncology.

Urinary incontinence in prostate cancer patients treated with external beam radiotherapy.

M. Keyes, S. Tyldesley, M. McKenzie, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The treatment of primary central nervous system lymphoma in 122 immunocompetent patients

R. Gascoyne, L. Sehn, J. Connors, 2005, Cancer.

Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial.

J. Mackey, L. Degner, T. Pickles, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Melbourne Consensus Statement on the early detection of prostate cancer

T. Ahlering, M. Cooperberg, M. Gleave, 2014, BJU international.

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program.

R. V. D. van den Bergh, M. Roobol, T. Pickles, 2012, European urology.

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.

C. Catton, É. Vigneault, J. Crook, 2015, International journal of radiation oncology, biology, physics.

Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death.

W. J. Morris, M. Keyes, S. Tyldesley, 2018, International journal of radiation oncology, biology, physics.

Facilitating the implementation of empirically valid interventions in psychosocial oncology and supportive care

L. Degner, L. Carlson, T. Pickles, 2011, Supportive Care in Cancer.

The treatment of choroidal melanoma with 198 Au plaque brachytherapy.

T. Pickles, R. Ma, C. Duzenli, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer.

C. Catton, D. Taussky, J. Crook, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy.

W. J. Morris, M. Keyes, T. Pickles, 2017, Brachytherapy.

Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: impact of the EORTC22863 and RTOG 85-31 and 92-02 trials.

M. Keyes, S. Tyldesley, T. Pickles, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

In regards to Thames et al.: increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (Int J Radiat Oncol Biol Phys 2006;65:975-981).

T. Pickles, Scott G. Williams, S. Williams, 2007, International journal of radiation oncology, biology, physics.

Presenting stage and risk group in men dying of prostate cancer.

S. Tyldesley, T. Pickles, F. Bachand, 2020, Current oncology.

Radiotherapy for muscle-invasive urinary bladder cancer in elderly patients.

A. Agranovich, T. Pickles, W. Kwan, 2002, The Canadian journal of urology.

The case for dose escalation versus adjuvant androgen deprivation therapy for intermediate risk prostate cancer.

A. Pollack, T. Pickles, 2006, The Canadian journal of urology.

Long-Term Outcomes for Patients With Limited-Stage Follicular Lymphoma: Update of a Population-based Study.

L. Sehn, J. Connors, K. Savage, 2020, Blood.

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study

H. G. van der Poel, M. Roobol, T. Pickles, 2018, Translational andrology and urology.

The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapy.

G. Duncan, S. Tyldesley, T. Pickles, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

P. Warde, T. Pickles, G. Morton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer

C. Catton, J. Crook, G. Rodrigues, 2015, Cureus.

Underutilization of local salvage therapy after radiation therapy for prostate cancer.

S. Tyldesley, T. Pickles, P. Black, 2014, Urologic oncology.

Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study

H. G. van der Poel, E. Steyerberg, R. V. D. van den Bergh, 2010, BJU international.

Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer.

T. Pickles, K. Chi, Ada Man, 2003, The Journal of urology.

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

Christopher P. Filson, D. Nieboer, E. Steyerberg, 2021, European urology open science.

Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer.

F. Saad, L. Klotz, T. Pickles, 2020, The Journal of urology.

Incomplete testosterone suppression with luteinizing hormone‐releasing hormone agonists: does it happen and does it matter?

W. J. Morris, S. Tyldesley, T. Pickles, 2012, BJU international.

A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer.

M. Brundage, W. Mackillop, R. Pearcey, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mL.

T. Pickles, Mitchell C C Liu, E. Berthelet, 2005, International journal of radiation oncology, biology, physics.

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study

M. Roobol, T. Pickles, A. Rannikko, 2021, Prostate Cancer and Prostatic Diseases.

Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.

M. Roobol, T. Pickles, A. Alberts, 2015, European urology.

Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study

M. Roobol, A. Semjonow, T. Pickles, 2016, BJU international.

Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia.

Michael D. Peacock, S. Tyldesley, T. Pickles, 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

M. Gleave, F. Saad, L. Klotz, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists.

M. Keyes, T. Pickles, E. Berthelet, 2011, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Population-based study of cardiovascular mortality among patients with prostate cancer treated with radical external beam radiation therapy with and without adjuvant androgen deprivation therapy at the British Columbia Cancer Agency.

S. Tyldesley, T. Pickles, R. Woods, 2011, International journal of radiation oncology, biology, physics.

An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk.

T. Pickles, J. Millar, S. Turner, 2006, International journal of radiation oncology, biology, physics.

Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy.

G. Duncan, S. Tyldesley, A. Agranovich, 2006, International journal of radiation oncology, biology, physics.

The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer

T. Pickles, P. Blood, 2007 .

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study.

M. Roobol, T. Pickles, Xiaoye Zhu, 2012, European urology.

Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy.

T. Pickles, 2006, International journal of radiation oncology, biology, physics.

141 Acute and Late Urinary Toxicity in 606 Prostate Brachytherapy Patients

M. Keyes, V. Moravan, T. Pickles, 2006 .

Technology review: high-intensity focused ultrasound for prostate cancer.

T. Pickles, L. Goldenberg, G. Steinhoff, 2005, The Canadian journal of urology.

Development of indicators of the quality of radiotherapy for localized prostate cancer.

M. Brundage, W. Mackillop, R. Pearcey, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The changing face of prostate cancer in British Columbia 1988-2000.

T. Pickles, A. Coldman, N. Phillips, 2002, The Canadian journal of urology.

The Relationship between Hot Flashes and Testosterone Recovery after 12 Months of Androgen Suppression for Men with Localised Prostate Cancer in the ASCENDE-RT Trial.

W. J. Morris, S. Tyldesley, T. Pickles, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

What happens to testosterone after prostate radiation monotherapy and does it matter?

T. Pickles, P. Graham, 2002, The Journal of urology.

Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma

W. J. Morris, M. Keyes, G. Duncan, 2002, Cancer.

What happens to testosterone after prostate radiation monotherapy, and does it matter

T. Pickles, Peter Graham, 2001 .

Pions--the potential for therapeutic gain in locally advanced prostate cancer: dose escalation and toxicity studies.

T. Pickles, P. Dixon, D. Rheaume, 1991, International journal of radiation oncology, biology, physics.

The Optimum Duration of Combination Androgen Deprivation Therapy (ADT) with Prostate Cancer Radiotherapy: Determining the Duration-benefit Relationship from Multi-institutional Analysis

L. Kestin, T. Pickles, G. Duchesne, 2008 .

Report on the quality of life analysis from the phase III trial of pion versus photon radiotherapy in locally advanced prostate cancer.

G. Duncan, T. Pickles, N. Philips, 2000, European journal of cancer.

Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.

Michael D. Peacock, S. Salcudean, Golnoosh Samei, 2020, Brachytherapy.

Prostate cancer radiotherapy 2002: the way forward.

C. Catton, P. Warde, T. Pickles, 2005, The Canadian journal of urology.

Impact of neoadjuvant prostate-specific antigen kinetics on biochemical failure and prostate cancer mortality: results from a prospective patient database.

Mariel S. Lavieri, M. Lavieri, T. Pickles, 2013, International journal of radiation oncology, biology, physics.

Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control.

L. Sullivan, T. Pickles, I. Syndikus, 1996, The Journal of urology.

Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.

T. Pickles, J. Oliffe, B. Davison, 2009, Oncology nursing forum.

Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.

T. Pickles, D. McLaren, P. Olive, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy.

R. Gascoyne, K. Savage, T. Pickles, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Limited‐stage diffuse large B‐cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy

R. Gascoyne, L. Sehn, J. Connors, 2012, Cancer.

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

R. Gascoyne, J. Connors, K. Savage, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of surveillance imaging after curative‐intent radiotherapy for limited‐stage follicular lymphoma

D. Scott, L. Sehn, K. Savage, 2021, British journal of haematology.

4-hydroxyandrostenedione--further clinical and extended endocrine observations.

T. Pickles, P. Murray, P. Plowman, 1990, British Journal of Cancer.

Intervention after PSA failure: examination of intervention time and subsequent outcomes from a prospective patient database.

T. Pickles, C. Kim-sing, 2004, International journal of radiation oncology, biology, physics.

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

R. Gascoyne, D. Scott, L. Sehn, 2015 .

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS)

M. Roobol, T. Pickles, A. Rannikko, 2015, World Journal of Urology.

Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency

T. Pickles, R. Ma, B. Weber, 2015, Ocular Oncology and Pathology.

Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.

E. Blackmore, T. Pickles, E. Tran, 2012, International journal of radiation oncology, biology, physics.

The Dosimetric Impact of Supplementing Pre-Planned Prostate Implants With Discretionary 125I Seeds

I. Spadinger, M. Keyes, N. Chng, 2011 .

GU radiation oncologists consensus on bone loss from androgen deprivation.

G. Duncan, P. Warde, T. Pickles, 2006, The Canadian journal of urology.

Intersociety Radiation Oncology Summit-SCOPE II.

K. Ang, A. Zietman, C. Willett, 2008, International Journal of Radiation Oncology, Biology, Physics.

Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials

R. Gascoyne, L. Sehn, J. Connors, 2010 .

The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy.

R. Gascoyne, K. Savage, F. Bénard, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis.

W. J. Morris, I. Spadinger, M. Keyes, 2022, Brachytherapy.

Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.

G. Duncan, T. Pickles, I. Syndikus, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Re: Hermann et al., low testosterone levels and quality of life.

G. Duncan, T. Pickles, P. Graham, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Small cell carcinoma of the bladder

L. Sullivan, C. Lohrisch, T. Pickles, 1999, Cancer.

Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

D. Nieboer, B. Trock, P. Dasgupta, 2022, European urology open science.

The effect of smoking on outcome following external radiation for localized prostate cancer.

S. Tyldesley, T. Pickles, W. Kwan, 2004, The Journal of urology.

752 TESTOSTERONE BREAKTHROUGH DURING LHRH AGONIST ANDROGEN DEPRIVATION WITH CURATIVE RADIATION: IMPACT ON PSA KINETICS AND SUBSEQUENT BIOCHEMICAL OUTCOMES

S. Tyldesley, T. Pickles, 2011 .

Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement.

C. Guillemette, F. Saad, L. Klotz, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Prostate cancer and host metabolic factors.

D. Palma, T. Pickles, 2008, The Lancet. Oncology.

The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia.

Michael D. Peacock, S. Tyldesley, T. Pickles, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics.

L. Kestin, H. Sandler, T. Pickles, 2011, International journal of radiation oncology, biology, physics.

Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer

S. Tyldesley, D. Palma, T. Pickles, 2007, BJU international.

PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy.

T. Pickles, C. Paltiel, A. Bates, 2005, International journal of radiation oncology, biology, physics.

Late results in patients treated with Pi‐mesons for bladder cancer

U. Studer, R. Kraft, T. Pickles, 1993, Cancer.

Pre-treatment risk stratification of prostate cancer patients: A critical review.

P. Warde, M. Brundage, J. Crook, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer.

L. Kestin, T. Pickles, M. Buyyounouski, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias.

Scott Tyldesley, Tom Pickles, W James Morris, 2003, International journal of radiation oncology, biology, physics.

Patterns of recurrence after low-dose-rate prostate brachytherapy: a population-based study of 2223 consecutive low- and intermediate-risk patients.

W. J. Morris, M. Keyes, S. Tyldesley, 2015, International journal of radiation oncology, biology, physics.

Active surveillance for low-risk prostate cancer.

Ewout W Steyerberg, Guido Jenster, Antti Rannikko, 2013, Critical reviews in oncology/hematology.

Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance

L. Carlson, T. Pickles, L. Weir, 2007, BJU international.

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

Ryan L. Smith, M. Stockler, G. Pond, 2018, International Journal of Radiation Oncology*Biology*Physics.

Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy

T. Pickles, M. Beasley, S. Williams, 2008, Radiation oncology.

Rising prostate-specific antigen values during neoadjuvant androgen deprivation therapy: The importance of monitoring.

T. Pickles, P. Niblock, 2006, International journal of radiation oncology, biology, physics.

Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: a population-based cohort study.

W. J. Morris, I. Spadinger, M. Keyes, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90%.

W. J. Morris, S. Tyldesley, M. Joffres, 2012, International journal of radiation oncology, biology, physics.

Predictors of androgen deprivation therapy efficacy combined with prostatic irradiation: the central role of tumor stage and radiation dose.

L. Kestin, T. Pickles, G. Duchesne, 2011, International journal of radiation oncology, biology, physics.

Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.

M. Stockler, G. Pond, H. Woo, 2018 .

Rectal Ulcers and Rectoprostatic Fistulas after (125)I Low Dose Rate Prostate Brachytherapy.

W. J. Morris, M. Keyes, S. Tyldesley, 2016, The Journal of urology.

Canadian prostate brachytherapy in 2012.

Nawaid Usmani, Tom Pickles, Mira Keyes, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia.

R. Gascoyne, D. Scott, L. Sehn, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Results of PET-Guided Radiation in Advanced-Stage Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.

D. Scott, L. Sehn, J. Connors, 2020, Blood.

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20‐year British Columbia Cancer Agency experience

R. Gascoyne, L. Sehn, J. Connors, 2017, British journal of haematology.

Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial.

W. J. Morris, M. Keyes, T. Pickles, 2018, Brachytherapy.

Watchful waiting or watchful progression?

G. Duncan, T. Pickles, D. McLaren, 1998, Cancer.

Watchful waiting or watchful progression?

G. Duncan, T. Pickles, D. McLaren, 1998, Cancer.

Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.

T. Pickles, J. Rootman, R. Ma, 2014, American journal of ophthalmology.

Secondary malignancy following radiotherapy for thyroid eye disease.

T. Pickles, Christopher C. Gillis, Eun Hae Estelle Chang, 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival.

W. J. Morris, I. Spadinger, M. Keyes, 2014, International journal of radiation oncology, biology, physics.

Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?

W. J. Morris, I. Spadinger, M. Keyes, 2010, International journal of radiation oncology, biology, physics.

Adjuvant radiotherapy following radical prostatectomy: Genito-Urinary Radiation Oncologists of Canada Consensus Statement.

P. Warde, T. Pickles, G. Morton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Telomerase and the benefits of healthy living

D. Palma, T. Pickles, 2008 .

Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.

K Otto, M Schmuland, W J Morris, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Long‐term outcomes for patients with limited stage follicular lymphoma

R. Gascoyne, J. Connors, K. Savage, 2010, Cancer.

Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy.

R. Gascoyne, K. Savage, T. Pickles, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcome of Primary Mediastinal Large B-cell Lymphoma Using R-CHOP: Impact of a PET Adapted Approach.

D. Scott, L. Sehn, J. Connors, 2020, Blood.

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

M. Roobol, H. Vergunst, T. Pickles, 2013, European urology.

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.

M. Roobol, T. Pickles, A. Rannikko, 2016, European urology.

Treatment Outcomes of Low-grade Lymphoma of the Orbit.

T. Pickles, C. Holloway, E. Wai, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada

S. Tyldesley, T. Pickles, S. Virani, 2015, Journal of oncology.

leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol

R. Gascoyne, K. Savage, T. Pickles, 2013 .

Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy?

T. Pickles, J. Hamm, J. Caon, 2014, Prostate cancer.

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.

I. Spadinger, M. Keyes, J. Crook, 2015, Brachytherapy.

Use of combined androgen blockade for advanced prostate cancer in British Columbia

T. Pickles, P. Blood, J. Barnett, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

R. Gascoyne, L. Sehn, J. Connors, 2010 .

Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review

L. Sehn, J. Connors, K. Savage, 2022, Leukemia & lymphoma.

Is prostate cancer screening cost‐effective? A microsimulation model of prostate‐specific antigen‐based screening for British Columbia, Canada

Ruth Etzioni, S. Tyldesley, S. Peacock, 2014, International journal of cancer.

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD

R. Gascoyne, D. Scott, L. Sehn, 2018, Haematologica.

Radiation therapy in prostate cancer: a risk-adapted strategy.

C. Catton, T. Pickles, A. Hayden, 2010, Current oncology.

Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure.

Richard J Lee, T. Pickles, R. Shaffer, 2011, International journal of radiation oncology, biology, physics.

Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance.

Alvaro Martinez, L. Kestin, A. Hanlon, 2008, International journal of radiation oncology, biology, physics.

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure

P. Carroll, A. Villers, M. Roobol, 2017, Nature Reviews Urology.

What's a man to do? Treatment options for localized prostate cancer.

T. Pickles, 2004, Canadian family physician Medecin de famille canadien.

The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis.

C. Catton, P. Warde, M. Brundage, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Re: Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer.

F. Saad, L. Klotz, T. Pickles, 2020, The Journal of urology.

Behind closed doors: systematic analysis of breast cancer consultation communication and predictors of satisfaction with communication

L. Degner, T. Pickles, T. Hack, 2010, Psycho-oncology.

Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role

J. Mackey, L. Degner, T. Pickles, 2010, Psycho-oncology.

Controversies in prostate cancer radiotherapy: consensus development.

L Souhami, G Morton, M. Brundage, 2001, The Canadian journal of urology.

The Impact of Explicit Values Clarification Exercises in a Patient Decision Aid Emerges After the Decision Is Actually Made

Deb Feldman-Stewart, Christine Tong, Tom Pickles, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

The Self-Management of Uncertainty Among Men Undertaking Active Surveillance for Low-Risk Prostate Cancer

T. Pickles, J. Oliffe, B. Davison, 2009, Qualitative health research.

Long‐Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate Brachytherapy

M. Keyes, J. Crook, M. McKenzie, 2018, The Journal of urology.

Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada.

C. Ménard, P. Warde, A. Berlin, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients

Catherine Han Lin, M. Kattan, D. Nieboer, 2021, Translational Andrology and Urology.

A first step towards a global nomogram to predict disease progression for men on active surveillance

Catherine Han Lin, M. Kattan, D. Nieboer, 2020, Translational andrology and urology.

Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi‐site, randomized, controlled trial

L. Degner, T. Pickles, T. Hack, 2007, Psycho-oncology.

The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000.

Tom Pickles, T. Pickles, Norm Phillips, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.

Howard Pai, Ingrid Spadinger, Stacy Miller, 2009, International journal of radiation oncology, biology, physics.

Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve?

Joseph Bucci, Michael McKenzie, Tom Pickles, 2006, International journal of radiation oncology, biology, physics.

Small cell carcinoma of the bladder: A population-based analysis of long-term outcomes after radical cystectomy and bladder conservation with chemoradiotherapy.

Carlos F. Villamil, S. Tyldesley, T. Pickles, 2021, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.

W. J. Morris, M. Keyes, S. Tyldesley, 2014, International journal of radiation oncology, biology, physics.

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.

C. Catton, É. Vigneault, J. Crook, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up.

W. J. Morris, I. Spadinger, M. Keyes, 2009, International journal of radiation oncology, biology, physics.

Behind closed doors II: systematic analysis of prostate cancer patients' primary treatment consultations with radiation oncologists and predictors of satisfaction with communication

L. Degner, T. Pickles, T. Hack, 2012, Psycho-oncology.

Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis.

W. J. Morris, M. Keyes, T. Pickles, 2010, International journal of radiation oncology, biology, physics.

Relationship between delay in radiotherapy and biochemical control in prostate cancer.

G. Duncan, T. Pickles, W. Kwan, 2006, International journal of radiation oncology, biology, physics.

PSA failure and the risk of death in prostate cancer patients treated with radiotherapy.

W. J. Morris, M. Keyes, G. Duncan, 2004, International journal of radiation oncology, biology, physics.

PSA relapse definitions--the Vancouver Rules show superior predictive power.

W. J. Morris, G. Duncan, T. Pickles, 1999, International journal of radiation oncology, biology, physics.

Real‐Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models

Yongseok Park, Donna P Ankerst, Tom Pickles, 2013, Biometrics.

Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma

L. Sehn, J. Connors, K. Savage, 2022, Leukemia & lymphoma.

Complications of prostate cancer treatment.

R. Halperin, T. Pickles, B. Maas, 2014, The Lancet. Oncology.

Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy.

S. Tyldesley, D. Palma, T. Pickles, 2007, International journal of radiation oncology, biology, physics.

Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals.

W. J. Morris, I. Spadinger, M. Keyes, 2014, International journal of radiation oncology, biology, physics.

Feasibility of an Audiotape Intervention for Patients with Cancer

L. Degner, T. Pickles, T. Hack, 2000 .

Current status of PSA screening. Early detection of prostate cancer.

Tom Pickles, T. Pickles, 2004, Canadian family physician Medecin de famille canadien.

Pretreatment prostate‐specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen‐deprivation therapy

S. Tyldesley, D. Palma, T. Pickles, 2008, Cancer.

Androgen deprivation therapy and prostate cancer duration.

T. Pickles, M. Buyyounouski, S. Williams, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy.

M. Keyes, G. Duncan, S. Tyldesley, 2004, International journal of radiation oncology, biology, physics.

Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review.

L. Sehn, J. Connors, T. Pickles, 2020, Practical radiation oncology.

Pion conformal radiation of prostate cancer: results of a randomized study.

W. J. Morris, G. Duncan, T. Pickles, 1999, International journal of radiation oncology, biology, physics.

A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systems.

L. Potters, L. Kestin, T. Pickles, 2006, International journal of radiation oncology, biology, physics.

The prostate cancer risk stratification project: database construction and risk stratification outcome analysis.

C. Catton, P. Warde, M. Brundage, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Outcome of limited stage nodular lymphocyte predominant Hodgkin lymphoma and the impact of a PET-adapted approach.

R. Gascoyne, D. Scott, L. Sehn, 2021, Blood advances.

Hormone use after radiotherapy failure: a survey of Canadian uro-oncology specialists.

L. Klotz, T. Pickles, P. Cheung, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer.

Michael W Kattan, Tom Pickles, Mira Keyes, 2011, Brachytherapy.

Four-week arc radiotherapy for B2-C prostate cancer: the need for prospective evaluation of short fractionation schemes.

W. J. Morris, T. Pickles, P. Graham, 1997, Australasian radiology.

MALPRACTICE IN RADIATION ONCOLOGY: REDEFINING THE ROLE OF THE MEDICAL EXPERT: IN REGARD TO KAGAN (INT J RADIAT ONCOL BIOL PHYS 2005;61:638-639)

T. Pickles, P. Maccallum, Scott Williams, 2005 .

Concurrent Modified PCV Chemotherapy and Radiotherapy in Newly Diagnosed Grade IV Astrocytoma

M. Knowling, T. Pickles, B. Thiessen, 2002, Journal of Neuro-Oncology.

Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy.

W. J. Morris, I. Spadinger, M. Keyes, 2015, Brachytherapy.

Decline in acute urinary toxicity: a long-term study in 2011 patients with prostate brachytherapy within a provincial institution.

W. J. Morris, I. Spadinger, M. Keyes, 2014, Brachytherapy.

Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

Howard Pai, William James Morris, Ingrid Spadinger, 2013, Brachytherapy.

Joint modelling of longitudinal and multi‐state processes: application to clinical progressions in prostate cancer

Virginie Rondeau, Cécile Proust-Lima, Hélène Jacqmin-Gadda, 2015, Statistics in medicine.

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database

Catherine Han Lin, D. Nieboer, E. Steyerberg, 2022, The Prostate.

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

D. Scott, L. Sehn, J. Connors, 2019, Blood.

Validating the Interval to Biochemical Failure for the Identification of Potentially Lethal Prostate Cancer

L. Kestin, T. Pickles, M. Buyyounouski, 2009 .

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program.

R. V. D. van den Bergh, M. Roobol, T. Pickles, 2012, European urology.

Prostate-specific antigen kinetics after failure of primary prostate cancer therapy: a valuable prognostic factor.

T. Pickles, 2007, Future oncology.

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.

M. Roobol, T. Pickles, A. Rannikko, 2016, European urology.

Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.

T. Pickles, J. Oliffe, B. Davison, 2009, Oncology nursing forum.

Pion radiation for high grade astrocytoma: results of a randomized study.

G. Duncan, T. Pickles, C. Fryer, 1997, International journal of radiation oncology, biology, physics.

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

D. Scott, L. Sehn, J. Connors, 2019, Blood.

Radiation therapy in prostate cancer: a risk-adapted strategy.

C. Catton, T. Pickles, A. Hayden, 2010, Current oncology.

Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics.

L. Kestin, H. Sandler, T. Pickles, 2011, International Journal of Radiation Oncology, Biology, Physics.

Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up.

I. Spadinger, M. Keyes, V. Moravan, 2009, International journal of radiation oncology, biology, physics.

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival.

I. Spadinger, M. Keyes, M. McKenzie, 2014, International journal of radiation oncology, biology, physics.

Impact of neoadjuvant androgen ablation and other factors on late toxicity following external beam prostate radiation

M. Keyes, G. Duncan, S. Tyldesley, 2002 .